/
2025-03-24 Steering Committee Meeting Notes

Date

Mar 24, 2025

Attendees

(bolded names indicate attendance)

Stakeholder group

SHIELD organization

Name of SHIELD member

organization designation

Industry Entity

Labgnostic, Inc.

Steve Box

primary

 


alternate

Epic

Dan Rutz

primary

 

 

alternate

Biomerieux

Xavier Gansel

primary

 

 

alternate

Roche

Nick Decker

primary

Roche

Yue Jin

alternate

Healthcare Provider

Indiana University/Indiana University Health/Association for Molecular Pathology

Mehdi Nassiri, MD

primary

University of Wisconsin-Madison

Andrea Pitkus, PhD, MLS(ASCP)CM, FAMIA

primary

UT Southwestern Medical Center

Hung Luu

primary

UNMC

Scott Campbell

primary

OPEN

OPEN

primary

Sonic Healthcare

Eric Crugnale

primary

Former Quest Diagnostics - OPEN?

Collom, Craig D

primary

Patient Advocate

 OPEN

OPEN

individual

Standards Organization

SNOMED International

 

Jim Case

primary

Monica Harry

alternate

Regenstrief Institute

 

Marjorie Rallins

primary

Eza Hafeza

alternate

HL7

 

Julia Skapik

primary

 

alternate

Professional Organization

Association of Public Health Laboratories

 

Riki Merrick

primary

Christina Gallegos

alternate

Graphite Health

 

Stan Huff

primary

 

alternate

CAP

 

Raj Dash - regrets

primary

 

alternate

AMP

 

Robyn Temple

primary

 

alternate

Governmental - non Voting

CMS

Michael Smalara

primary

Open

alternate

ASTP/ONC

Sara Armson

primary

 

alternate

CDC

Hubert Vesper (/DDNID/NCEH/DLS)

primary

Jasmine Chaitram

alternate

NLM

 John Snyder

primary

 

alternate

FDA

 Keith Campbell

primary

Victoria Derbyshire

alternate

Agenda and Notes

Item

Notes

Quorum evaluation (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business)

Currently we have 17 named members (2 open slots), so 2/3 = 11 is quorum (excluding chair and government members).

# of voting member per charter: 13 - 21

# of non-voting members per charter: 7

 

Open Meeting

1:07 PM ET, no quorum

Conferences/Time critical things

AMIA November 15 - 19 in Atlanta, GA https://amia.org/education-events/amia-2025-annual-symposium/call-participation submitted proposal

LOINC 7-10 October in Montreal, Canada - proposals are open till 3/30 https://loinc.org/conference/montreal-2025/presentations/

ASCLS presentation is scheduled for June 11, 2025, 8 - 9 AM PT

https://aphlinformatics.atlassian.net/wiki/spaces/SC/pages/3052175362 - when to work on this next?

Find New Meeting Time

https://www.when2meet.com/?29478083-E8yoY

Have 11 entries - none that work for everyone

Best spot first and second Wednesday 12 -1 PM ET, so will send meeting invite out for that timeslot

Update on Elections

Chair: Riki Merrick (Votes: 10 - Andrea Pitkus = 2)

Co-Chair: Andrea Pitkus (Votes: 8 - Riki Merrick = 1, Eric Crugnale = 4)

Thanks to all who voted and to Eric for putting his name in the hat.

SHIELD Charter Updates as shared via email sent to SC members on

https://aphlinformatics.atlassian.net/wiki/spaces/SC/pages/3071279178 - Review the updated Article Three of the Charter as a whole

Send off to Steering Committee for voting via email

Note: Changes to the Charter require unanimous approval by the Steering Committee

Steering Committee Composition

These slots are potentially open:

  • Healthcare Provider:

    • Nirmala resigned end of December - fill this position first via email vote - Riki will send separate email

    • Craig has not been participating on calls, would have to consider vote to terminate his SC participation, if we want to add more than one) - will discuss on our call on April 2

    • Have interest from these folks:

      • Jeffrey Smith from Kaiser Permanente

      • Carmen Pugh as individual

      • Mark Ediger as individual

  • 1 Patient Advocate (Stacy also resigned via email)

  • Composition of Steering Committee changes?

    • Expand by 2 members, which would make quorum 13 instead of the current 12 (once open slots are filled)

Review Working Groups progress

THANK YOU to all the WG Chairs for their effort in moving SHIELD work forward!!!

Setting milestones for deliverables should be NEXT for WGs: they will be captured here: SHIELD WG Deliverables and Milestone Grid

Review Items

https://aphlinformatics.atlassian.net/wiki/spaces/SC/pages/2020966449 was open for SC review and comment until Feb 21, 2025 - Riki has not received any via email, LIDR WG members comments all have been addressed - will extend the comment period to April 7th and discuss on the SC call on April 16th

https://www.jmdjournal.org/article/S1525-1578(21)00327-5/fulltext AMP paper - do we need to do something with this as the Steering Committee?

Roadmap section updates in response to ONC comments on the SHIELD roadmap

Riki will prep this section better before the next call - it has been a while since we looked at this one - ideally we’ll have complete updated roadmap document to approve soon.

  1. The roadmap mission section describes a broad vision of lab interoperability. However, the roadmap proposed solution is limited to the FDA use cases around In-vitro diagnostics (IVD) data, specifically populating the IVD data hub.  ONC suggests clearly describing the roadmap scope so the proposed solutions can be discussed within that context.

Updated language draft: Roadmap update: ONC Feedback

maybe add one more sentence or add a reference to the key consideration number for the IVD Datahub (Consideration 4) into these sentences. (change approved in principle.)

Discussion:

  • Updated roadmap:

  • Also need to remove the duplicate words “for the” in the last sentence

  • Anything else needed on this one?

  1. The roadmap identifies training and education needs around using LOINC as a barrier to interoperability. ONC suggests clarifying how the roadmap addresses this barrier. ONC recognizes that terminologies require training and education, and replacing LOINC with another standard will not address the barrier.

Update from Standards and Vocab WG about re-write of this section - from their March 18th call (notes here, recording here)

  1. Concepts around Healthcare IT (HIT) standards needs to be conveyed earlier in training for healthcare providers as use and application of standards in vended applications is the major gap.

  2. Decision making to use Health IT standards are less likely left up to IT analysts as they mainly follow the requirements and then they generally use vendor supplied implementation guidance. However, a vendor may not support functionality for standards or only partially support.

  3. Regulatory requirements (such as CLIA) may pose a hurdle to implementation of data standards.

  4. Implementation guidance is often not well read. Training resources may not be well publicized or readily available. Perhaps conformance testing tools need to be made more widely available?

  5. What might be helpful is to look at standards implementation from a data lifecycle standpoint across all users (end to end across ecosystem), rather than just training on a single standard for a single use case.

  6. Last paragraph on page 4 of the road map final version could be augmented with these points.

Discussion:

  • Need to find the exact space for these points, too

  1. There are several solutions proposed, including repositories and tools, which need to be further evaluated before ONC could fully support the roadmap.  ONC suggests the roadmap be updated to include details around feasibility, scalability and how the proposed changes can be integrated into the current laboratory ecosystem (e.g., regulation and industry).

Identify components that could improve the ecosystem infrastructure, and then highlight the places where these components can be advanced / sustained or made easier to implement. Would SHIELD be willing to consider to provide an example implementation - create the structures and bound terminologies to showcase how each element would be properly represented be working.

For each of the Consideration sections we could certainly add a section on feasibility / requirements (e.g. continued funding for LIDR, better describing the intended use of ANY data element added, overall goal of LIDR, clearly delineate what is commonly used and is minimum, provide best practice and alternatives (non-preferred) - example would be metadata around the value sets in VSAC (curation / usage etc) to be able to ascertain quality) and highlight that other mechanisms are needed to achieve for adoption.

Antimicrobial result reporting

Placeholder to get back to later

Related work at HL7 Europe:

https://www.jmdjournal.org/article/S1525-1578(21)00327-5/fulltext

Other presentations to folks at FDA?

  • Data Standards Review Committee of the FDA – work with Helena Sviglin

  • FDA Scientific Computing Board (SCB)

  • Compass group lab

Next calls

All SHIELD Calls

  • March 25th

  • April 22nd

General Updates: 2024 - WG Chairs please make sure we have material for updates (at least notes we can link to)

Special Topic:

  • March 25th LOINC Ontology Presentation

  • April 8th Synensys Report update

  • May 13th that is during HL7 WGM, but that is in Madrid, Spain, so may not affect that many folks

Steering Committee:

  • March 24th

  • New day/time: April 2 and 16th at12n EST

    • Send new meeting invites

  • Not scheduled after this - decide on new day/time:

    • Cancel April 7 and April 21.

Adjourned

 154 PM ET

From Chat:


Action items



Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.



Decisions requiring context or tracking

For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.

Create from Template